Increased prevalence of hypertension and long-term arsenic exposure

Hypertension

Volumn 25, Issue 1, 1995, Pages 53-60

  Chen, Chien Jen ^a,c   Hsueh, Yu Mei ^b   Lai, Mei Shwu ^a   Shyu, Mei Pyng ^a   Chen, Shu Yuan ^a   Wu, Meei Maan ^a   Kuo, Tsung Li ^b   Tai, Tong Yuan ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

arsenic; hypertension, essential; prevalence

Indexed keywords

ARSENIC; DRINKING WATER; WELL WATER;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLACKFOOT DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TAIWAN; WATER CONTAMINATION;

EID: 0028961576     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.25.1.53     Document Type: Article

References (33)

1. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Metals and Metalloid Compounds. Lyon, France: International Agency for Research on Cancer; 1980;23:39-141.
2. World Health Organization. Environmental Health Criteria 18: Arsenic. Geneva, Switzerland: World Health Organization; 1981:43-102.
3. Smith AH, Hopehayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992;97:259-267.
4. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1968;19:109-119.
5. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8:452-460.
6. Wu MM, Kuo TL, Huang YH, Chen CJ. Dose-response relationship between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989;130:1123-1132.
7. Chen CJ. Blackfoot disease. Lancet. 1990;336:442.
8. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
9. Tseng WP. Outcome of untreated hypertensives in an agricultural population: a 15-year follow-up study. J Formos Med Assoc. 1980;79:556-563.
10. Tsai HC, Yen TS, Wang LT, Cheng JT, Tseng WP, Chen CM. An epidemiologic study of the cardiovascular diseases among the inhabitants of a fishing village in Taiwan. Report 1: Blood pressure and hypertension. J Formos Med Assoc. 1966;65:249-258.
11. Wu HY, Chen KP, Tseng WP, Hsu CL. Epidemiologic studies on blackfoot disease: prevalence and incidence of the disease by age, sex, year, occupation, and geographic distribution. Memoirs of College of Medicine (National Taiwan University). 1961;7:1-18.
12. Kuo TL. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Reports of Institute of Pathology (College of Medicine, National Taiwan University). 1964;20:7-13.
13. Lo MC, Hsen YC, Lin BK. Arsenic Content of Underground Water in Taiwan: Second Report. Taichung, Taiwan Provincial Institute of Environmental Sanitation, 1977.
14. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2nd ed. Geneva, Switzerland: World Health Organization; 1982:82-85.
15. Chen YC. An Epidemiologic Study on Cardiovascular Risk Factors Among Residents in Chutung and Potzu Townships. Taipei, Taiwan: Institute of Public Health, National Taiwan University College of Medicine; 1990. Thesis.
16. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume I, The Analysis of Case-Control Studies. Geneva, Switzerland: World Health Organization; 1980:192-247.
17. Rosenberg HG. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol. 1974;97:360-365.
18. Zaldivar R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Beitr Path. 1974;151:384-400.
19. Borgono JM, Greiber R. Epidemiological study of arsenicism in the city of Antofagasta. In: Hemphill DC, ed. Trace Substances in Environmental Health, Proceedings of the 5th Annual Conference. Columbia, Mo: University of Missouri; 1972:13-24.
20. Salcedo JC, Portales A, Landecho E, Diaz R. Transverse study of a group of patients with vasculopathy from chronic arsenic poisoning in communities of the Francisco de Madero and San Pedro Districts, Coahuila, Mexico. Rev Fac Medicina Torren. 1984;12:16.
21. Committee on Medical and Biological Effects of Environmental Pollutants, Division of Medical Sciences, National Research Council. Arsenic. Washington, DC: National Academy of Sciences; 1977.
22. Axelson O, Dahlgren E, Jansson CD, Rehnlund SO. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med. 1978;35:8-15.
23. Lee AM, Fraumeni JF Jr. Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst. 1969;42:1045-1052.
24. Lagerkvist B, Linderholm H, Nordberg GF. Vasospastic tendency and Reynaud's phenomenon in smelter workers exposed to arsenic. Environ Res. 1986;39:465-474.
25. Zaldivar R. A morbid condition involving cardiovascular, broncho-pulmonary, digestive and neural lesions in children and young adults after dietary arsenic exposure. Zbl Bakt I Abt Orig. 1980;B170:44-56.
26. Chen KP, Wu HY, Wu TC. Epidemiologic studies on blackfoot disease in Taiwan, 3: physicochemical characteristics of drinking water in endemic blackfoot disease areas. Memoirs of College of Medicine (National Taiwan University). 1962;8:115-129.
27. Yeh SJ, Yang MH. Trace elements in water samples from the endemic area of blackfoot disease and biospecimens from blackfoot disease patients: a preliminary report. Blackfoot Disease Research Report. 1980;8:22-28.
28. Donofrio PD, Wilbourn AJ. Subacute arsenic toxicity presenting on clinical and electromyographic examination as Guillain-Barre syndrome. Ann Neurol. 1985;18:156-157.
29. Hindmarsh JT, McCurdy RF. Clinical and environmental aspects of arsenic toxicity. CRC Crit Rev Clin Lab Sci. 1986;23:315-347.
30. Gerhardt R, Hudson J, Rao R, Sobel R. Chronic renal insufficiency from cortical necrosis induced by arsenic poisoning. Br J Ind Med. 1978;138:1267-1269.
31. Hamamoto E. Infant arsenic poisoning by powdered milk. Jpn Med J. 1955;1649:2-12.
32. Lopez S, Miyashita Y, Simons SS Jr. Structurally based, selective interaction of arsenite with steroid receptor. J Biol Chem. 1990; 165:16039-16042.
33. Chen CJ, Lin LJ. Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In: Nriagu JO, ed. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. New York, NY: John Wiley & Sons, Inc; 1994:109-131.